Cargando…

In Vivo Organic Bioelectronics for Neuromodulation

[Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kH...

Descripción completa

Detalles Bibliográficos
Autores principales: Berggren, Magnus, Głowacki, Eric D., Simon, Daniel T., Stavrinidou, Eleni, Tybrandt, Klas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874920/
https://www.ncbi.nlm.nih.gov/pubmed/35050623
http://dx.doi.org/10.1021/acs.chemrev.1c00390
_version_ 1784657801755230208
author Berggren, Magnus
Głowacki, Eric D.
Simon, Daniel T.
Stavrinidou, Eleni
Tybrandt, Klas
author_facet Berggren, Magnus
Głowacki, Eric D.
Simon, Daniel T.
Stavrinidou, Eleni
Tybrandt, Klas
author_sort Berggren, Magnus
collection PubMed
description [Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kHz operating frequency, modern complementary metal oxide semiconductor (CMOS) based electronics appear to be the only technology platform at hand for such integration. However, conventional CMOS-based electronics rely exclusively on electronic signaling and therefore require an additional technology platform to translate electronic signals into the language of neurobiology. Organic electronics are just such a technology platform, capable of converting electronic addressing into a variety of signals matching the endogenous signaling of the nervous system while simultaneously possessing favorable material similarities with nervous tissue. In this review, we introduce a variety of organic material platforms and signaling modalities specifically designed for this role as “translator”, focusing especially on recent implementation in in vivo neuromodulation. We hope that this review serves both as an informational resource and as an encouragement and challenge to the field.
format Online
Article
Text
id pubmed-8874920
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-88749202022-02-28 In Vivo Organic Bioelectronics for Neuromodulation Berggren, Magnus Głowacki, Eric D. Simon, Daniel T. Stavrinidou, Eleni Tybrandt, Klas Chem Rev [Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kHz operating frequency, modern complementary metal oxide semiconductor (CMOS) based electronics appear to be the only technology platform at hand for such integration. However, conventional CMOS-based electronics rely exclusively on electronic signaling and therefore require an additional technology platform to translate electronic signals into the language of neurobiology. Organic electronics are just such a technology platform, capable of converting electronic addressing into a variety of signals matching the endogenous signaling of the nervous system while simultaneously possessing favorable material similarities with nervous tissue. In this review, we introduce a variety of organic material platforms and signaling modalities specifically designed for this role as “translator”, focusing especially on recent implementation in in vivo neuromodulation. We hope that this review serves both as an informational resource and as an encouragement and challenge to the field. American Chemical Society 2022-01-20 2022-02-23 /pmc/articles/PMC8874920/ /pubmed/35050623 http://dx.doi.org/10.1021/acs.chemrev.1c00390 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Berggren, Magnus
Głowacki, Eric D.
Simon, Daniel T.
Stavrinidou, Eleni
Tybrandt, Klas
In Vivo Organic Bioelectronics for Neuromodulation
title In Vivo Organic Bioelectronics for Neuromodulation
title_full In Vivo Organic Bioelectronics for Neuromodulation
title_fullStr In Vivo Organic Bioelectronics for Neuromodulation
title_full_unstemmed In Vivo Organic Bioelectronics for Neuromodulation
title_short In Vivo Organic Bioelectronics for Neuromodulation
title_sort in vivo organic bioelectronics for neuromodulation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874920/
https://www.ncbi.nlm.nih.gov/pubmed/35050623
http://dx.doi.org/10.1021/acs.chemrev.1c00390
work_keys_str_mv AT berggrenmagnus invivoorganicbioelectronicsforneuromodulation
AT głowackiericd invivoorganicbioelectronicsforneuromodulation
AT simondanielt invivoorganicbioelectronicsforneuromodulation
AT stavrinidoueleni invivoorganicbioelectronicsforneuromodulation
AT tybrandtklas invivoorganicbioelectronicsforneuromodulation